about
Neglected tropical diseases in sub-saharan Africa: review of their prevalence, distribution, and disease burdenEcology and transmission of Buruli ulcer disease: a systematic reviewGeneral Overview on Nontuberculous Mycobacteria, Biofilms, and Human InfectionDeforestation and avian infectious diseasesNanostructured platforms for the sustained and local delivery of antibiotics in the treatment of osteomyelitisPhase change material for thermotherapy of Buruli ulcer: a prospective observational single centre proof-of-principle trial.Household cost of out-patient treatment of Buruli ulcer in Ghana: a case study of Obom in Ga South Municipality.Under treated necrotizing fasciitis masquerading as ulcerated edematous Mycobacterium ulcerans infection (Buruli ulcer).Secondary Buruli ulcer skin lesions emerging several months after completion of chemotherapy: paradoxical reaction or evidence for immune protection?Severe multifocal form of buruli ulcer after streptomycin and rifampin treatment: comments on possible dissemination mechanisms.A theoretical model for the transmission dynamics of the Buruli ulcer with saturated treatment.Application of geographical information system (GIS) technology in the control of Buruli ulcer in Ghana.Mycobacterium ulcerans triggers T-cell immunity followed by local and regional but not systemic immunosuppression.Risk factors for buruli ulcer in Ghana-a case control study in the Suhum-Kraboa-Coaltar and Akuapem South Districts of the eastern region.Impact of human immunodeficiency virus on the severity of buruli ulcer disease: results of a retrospective study in cameroon.Spontaneous Healing of Mycobacterium ulcerans Lesions in the Guinea Pig ModelSpatial Distribution of Mycobacterium ulcerans in Buruli Ulcer Lesions: Implications for Laboratory Diagnosis.Metabolomic profiles delineate mycolactone signature in Buruli ulcer disease.Clinical Features of Spontaneous Partial Healing During Mycobacterium ulcerans Infection.Socio-cultural determinants of timely and delayed treatment of Buruli ulcer: Implications for disease control.Susceptibility Profiles of Mycobacterium ulcerans Isolates to Streptomycin and Rifampicin in Two Districts of the Eastern Region of Ghana.The Buruli Ulcer.Investigation of wild-type and mycolactone-negative mutant Mycobacterium ulcerans on skeletal muscle: IGF-1 protects against mycolactone-induced muscle catabolism.Financial burden of health care for Buruli ulcer patients in Nigeria: the patients' perspective.Secondary bacterial isolates from previously untreated Buruli ulcer lesions and their antibiotic susceptibility patterns in Southern Nigeria.FVB/N Mice Spontaneously Heal Ulcerative Lesions Induced by Mycobacterium ulcerans and Switch M. ulcerans into a Low Mycolactone Producer.Findings in patients from Benin with osteomyelitis and polymerase chain reaction-confirmed Mycobacterium ulcerans infection.A molecular approach to identifying the natural prey of the African creeping water bug Naucoris, a potential reservoir of Mycobacterium ulcerans.Mycobacterium ulcerans infection in two alpacas.Buruli Ulcer, a Prototype for Ecosystem-Related Infection, Caused by Mycobacterium ulcerans.Risk factors for Mycobacterium ulcerans infection (Buruli Ulcer) in Togo ─ a case-control study in Zio and Yoto districts of the maritime region.Assessment of health care workers' knowledge, attitude and risk perception of Buruli ulcer disease in Southern Nigeria.OceaniaModeling the transmission of Buruli ulcer in fluctuating environments
P2860
Q21092296-79A0C478-0C39-4242-8FF5-CB4E4E69CCB9Q21144518-CF191157-CE4F-4A9E-A930-A8E582145167Q26776061-653FC246-BCE0-4F8A-B605-70E6EC5BE569Q27490986-D1395E89-2CE5-462C-863E-C639F7DF1A73Q28086953-A27E19DF-FC29-46D6-9C2B-9556C5DA0DEFQ33409842-1422F051-0B91-4829-8A74-F8408358D86CQ33642236-9A5C3F33-12AB-4C7C-ADEB-5F9551607762Q33693677-6DECEA0E-1E28-4229-9074-F27B74D0BD0DQ33988898-72307565-41AC-472A-A661-7363B91F1617Q34024822-3703C451-8CFE-427D-8C65-F868AB571854Q34152020-75097EA8-E89B-4A12-A7A0-E29D530628E3Q34467770-BF88F5CF-E586-407E-8B85-8F9F05E2468EQ34484489-4A518D2A-9429-4CAC-AB30-7C663EA4CE9FQ34549636-29319D37-9821-4EC0-A382-07DF492006C7Q35071988-593DA3DD-2426-424F-AC0B-28968D2F9A11Q35857386-E1100A2D-C6B1-4DBD-8822-6AA9044D5007Q36037938-14C58703-603C-437E-8A8B-04A9104A4542Q36346380-066C3EEE-2E4C-48BF-9216-70CFFC2CB215Q36618316-946326C8-BC0B-4C33-8375-D72CEB61B9F2Q37008208-B82015C3-88C3-458A-AC33-01EA42C94B79Q37539074-915059BC-9478-41C5-9317-42E3CDC074B2Q38569307-80E76FB7-DCE2-403F-B9E2-31F6428885B8Q38979254-78BAC10A-E2BC-4B17-84AE-44E0005FC242Q39093498-AE643706-2140-4642-9298-B958F5AA6EADQ39162386-1E73D5A0-BBC9-4B42-947A-CA6E096EEEBFQ39215467-5E10CF05-8618-4F9D-80E9-5988A26FA7BAQ42205104-6C3A4E04-532C-41F2-B62E-D5599B7EDACAQ42469123-8657C816-9A24-47E8-ABA8-6D2B9BB37B38Q45346929-C5CD7B71-B9AE-467A-B9A9-522A3ED3038AQ46241939-F8725D8E-DB63-45C1-B01B-082A55E8CE7FQ47709186-233A1A98-A008-4B37-B704-0EC811265B72Q49679513-1C76CA02-6C33-499C-9187-A3A85410F1BBQ56744800-6494D567-8FD1-45DA-8B8F-DE0A1F46AB08Q57032440-7D2D177D-A29C-4F12-826D-FF6734318541
P2860
description
2008 nî lūn-bûn
@nan
2008 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
name
Buruli ulcer (Mycobacterium ulcerans infection).
@ast
Buruli ulcer (Mycobacterium ulcerans infection).
@en
Buruli ulcer
@nl
type
label
Buruli ulcer (Mycobacterium ulcerans infection).
@ast
Buruli ulcer (Mycobacterium ulcerans infection).
@en
Buruli ulcer
@nl
prefLabel
Buruli ulcer (Mycobacterium ulcerans infection).
@ast
Buruli ulcer (Mycobacterium ulcerans infection).
@en
Buruli ulcer
@nl
P2093
P1476
Buruli ulcer (Mycobacterium ulcerans infection).
@en
P2093
Douglas S Walsh
Françoise Portaels
Wayne M Meyers
P304
P356
10.1016/J.TRSTMH.2008.06.006
P577
2008-07-26T00:00:00Z